22nd European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID)
31.03.2012 - 03.04.2012
1. Please select a day:
31.03.2012
01.04.2012
02.04.2012
03.04.2012
Publication only
Search

Personal programme
Please enter your email address here in order to bring up your personal programme




Home


Monday, April 02, 2012

- Click on a checkbox to select a whole session.
- Session titles which are underlined can be clicked upon to show further details.
- Individual programme items can also be selected.
- Go to another day to select further points or click on display to show your saved personal programme.
07:45 Schistosomiasis - a challenge for ID specialists?! (Meet-the-Expert)
07:45 Central line bacteraemias: can we truly aim at zero (Meet-the-Expert)
07:45 Diagnosis of fungal infections (Meet-the-Expert)
07:45 How to plan and report your study: your boarding pass for publication (Meet-the-Expert)
07:45 Management of ESBL producers in Enterobacteriaceae in the ICU; E. coli, K. pneumoniae, ... all the same? (Meet-the-Expert)
07:45 ESCMID Guideline for management of acute sore throat (Meet-the-Expert)
09:00 Emerging viral infections (Official Symposium)
09:00 Automation of the bacteriology lab; what, when and why (Official Symposium)
09:00 Careers for infectious disease physicians and clinical microbiologists: is there evidence of discrimination? (Official Symposium)
09:00 What does it take for a plasmid to 'go global'? It's all in the genes..... (Official Symposium)
09:00 Clinical and experimental immunology (Oral session)
09:00 New approaches to antibiotic use in serious infections (Oral session)
09:00 The role of new beta-lactams in an era of increasing global resistance (AstraZeneca Symposium)
09:00 Optimising care pathways in invasive fungal disease: new evidence and experience (Pfizer Symposium)
09:00 Impact of molecular diagnostics on patient pathways (Cepheid Symposium)
09:00 Current and future perspectives in clinical diagnosis of viral, bacterial and parasitic pathogens using a unique multiplexing technology (Luminex Symposium)
11:30 Are viruses the fourth domain of life? (Keynote Lecture)
11:30 Malaria diagnosis: cornerstone in combating malaria (Keynote Lecture)
11:30 HAI surveillance and public reporting: leading to real improvement and best practices? (Keynote Lecture)
11:30 The paradox of Propionibacterium acnes: benign commensal and virulent pathogen (Official Symposium)
11:30 Immunotherapy after transplantation: the present, the future (Official Symposium)
11:30 Severe streptococcal sepsis (Official Symposium)
11:30 The year in clinical microbiology (Official Symposium)
11:30 Are contact precautions sufficient to control spread of multidrug-resistant bacteria? - PRO/CON debate (Official Symposium)
11:30 NDM-1 - a growing problem (Oral session)
11:30 CMV in the compromised host: new information (Oral session)
12:30
POSTER SESSION IV
12:30 Antimicrobial resistance in isolates of non-human origin (Postersession)
12:30 Automation of the microbiology laboratory (Postersession)
12:30 Commercial systems for detection of antimicrobial resistance in Gram-positive organisms (Postersession)
12:30 ESBLs (Postersession)
12:30 Carbapenemases from all over the world (Postersession)
12:30 Epidemiology and genetics of clinical isolated carrying NDM (Postersession)
12:30 Commercially available systems for detection of ESBLs including KPC and AMPC (Postersession)
12:30 News on fluoroquinolone resistance (Postersession)
12:30 External quality assessment of resistance detection (Postersession)
12:30 Diagnostic microbiology methods - non-molecular (Postersession)
12:30 Molecular bacteriology - miscellaneous (Postersession)
12:30 Molecular diagnosis of gastrointestinal pathogens (Postersession)
12:30 Molecular diagnosis of sepsis and joint infections (Postersession)
12:30 Molecular diagnosis of sexually transmitted infections (Postersession)
12:30 Multidrug-resistant Gram-negative organisms - old and new strategies (Postersession)
12:30 Multidrug-resistant Pseudomonas aeruginosa (Postersession)
12:30 Late Breaking News (Postersession)
13:30
POSTER SESSION V
13:30 Bacteraemia, sepsis and infective endocarditis (Postersession)
13:30 Klebsiella infections in hospital and community settings (Postersession)
13:30 Staphylococcus aureus - antimicrobial activity and resistance to newer agents (Postersession)
13:30 Diagnosis of tuberculosis (Postersession)
13:30 Tuberculosis; clinical and molecular epidemiology and treatment (Postersession)
13:30 Infection control (miscellaneous) (Postersession)
13:30 Hand hygiene: what else? (Postersession)
13:30 Typing of typical and atypical isolates from emerging diseases (Postersession)
13:30 Emerging infectious diseases (Postersession)
13:30 Experimental and clinical immunology (Postersession)
13:30 Experimental and diagnostic aspects of Lyme borreliosis (Postersession)
13:30 Experimental treatment (animal model) of progeria bacterial infections (Postersession)
13:30 New aspects on helminth infections and intestinal protozoans (Postersession)
13:30 Viral infections in the compromised host (Postersession)
13:30 Internet and electronic resources (Postersession)
13:30 New clinical data on infections in compromised hosts (Postersession)
14:30
AFTERNOON SESSIONS
14:30 Cryptococcosis - clinical advice on an emerging global concern (Keynote Lecture)
14:30 Phage therapy: myth or reality? (Keynote Lecture)
14:30 Streptococcus pneumoniae; the perennial pathogen (Keynote Lecture)
14:30 Schistosomiasis (Official Symposium)
14:30 Toys, gadgets and e-sources for ID and CM specialists (Official Symposium)
14:30 The year in infection control (Official Symposium)
14:30 Solid organ transplantation in HIV-infected patients (Official Symposium)
14:30 Hepatitis E: an omnipresent zoonosis (Official Symposium)
14:30 Old and new emerging viral infections and warning systems for outbreaks (Oral Session)
14:30 Mycobacterial infections: science and medicine (Oral session)
16:00 Seen in the parasitology clinic (Official Symposium)
16:00 Faster, higher, stronger..and infection-free: a new motto for the Olympics? Infection and sporting events (Official Symposium)
16:00 Vaccine and cell therapy approaches in HIV infection (Official Symposium)
16:00 Risk factors for HAI: how many are modifiable in real life? (Official Symposium)
16:00 Non-MBL carbapenemases in Gram-negative bacilli (Official Symposium)
16:00 Bacteraemia and surgical site infections (Oral session)
16:00 European standardisation and automation in microbiology (BD Diagnostics Symposium)
16:00 Antifungal grand rounds: aligning management approaches with patient needs (Astellas Pharma EU Symposium)
16:00 Community-acquired LRTIs and cSSSIs: the challenge of choosing appropriate antimicrobial therapy (Bayer Pharma Symposium)
16:00 Interest in IT solutions to improve patient management (bioMérieux Symposium)